AstraZeneca

Views & Analysis
iStock 5380328781

Innovations in cancer drug research

While cancer continues to be one of the leading causes of death and illness, new technology and increasing use of real-world data have the potential to revolutionise care.

News
astrazeneca-sign

AZ to develop Parkinson's drug with Takeda

AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).